Revolution (RVMD) PT Raised to $73 at Jefferies

Jefferies analyst Kelly Shi raised the price target on Revolution (NASDAQ: RVMD) to $73.00 (from $63.00) while maintaining a Buy rating.

The analyst comments "With the new PDAC data, we think the odds are tipping even higher now for RVMD's multi-selective RASi to draw the period to "there's nothing for PDAC" based on the 8.1/4.2m mPFS in 2L/3L+ PDAC and the flattening OS curve up to 12m, both markedly improve from SoC chemo. Our KOL thinks such data is "practice-changing" in 2L and also bodes well for 1L where chemo has ~9-12m mOS, and add'l 3m OS would be meaningful. We increase 2L PDAC PoS from 40% to 50% - PT $73."

You May Also Be Interested In

• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• National Bank Financial Upgrades Wesdome Gold Mines Ltd. (WDO:CN) (WDOFF) to Outperform